Response Biomedical Corp (RPBIF) SEC Filing 8-K Material Event for the period ending Monday, March 21, 2016

Response Biomedical Corp

CIK: 806888 Ticker: RPBIF

View differences made from one to another to evaluate Response Biomedical Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Response Biomedical Corp.


Assess how Response Biomedical Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Response Biomedical Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2016 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: RPBIF
CIK: 806888
Form Type: 8-K Corporate News
Accession Number: 0001437749-16-028282
Submitted to the SEC: Wed Mar 23 2016 4:03:58 PM EST
Accepted by the SEC: Wed Mar 23 2016
Period: Monday, March 21, 2016
Industry: Testing Laboratories
  1. Earnings Release
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: